Blood cancers, High grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)
Results
Phase 1/2
This trial looked at changing immune cells to recognise and attack diffuse B cell lymphoma. The people taking part had their own immune cells called changed. This treatment is called CAR T-cell treatment.
The trial was for people with diffuse B cell lymphoma (DBCL) who had not had CAR T-cell treatment before. And their lymphoma had come back after treatment, or treatment had stopped working.
The trial was open for people to join between 2017 and 2021. The team published the results in 2023.
Recruitment start: 1 September 2017
Recruitment end: 3 November 2021
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Kirit Ardeshna
Autolus Ltd
Last reviewed: 25 Jun 2024
CRUK internal database number: 15428
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
